首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   35166篇
  免费   6345篇
  国内免费   108篇
耳鼻咽喉   240篇
儿科学   1021篇
妇产科学   2110篇
基础医学   2391篇
口腔科学   414篇
临床医学   17368篇
内科学   5152篇
皮肤病学   328篇
神经病学   2410篇
特种医学   461篇
外科学   2598篇
综合类   249篇
一般理论   21篇
预防医学   3735篇
眼科学   168篇
药学   1183篇
中国医学   31篇
肿瘤学   1739篇
  2024年   105篇
  2023年   966篇
  2022年   492篇
  2021年   983篇
  2020年   1091篇
  2019年   912篇
  2018年   1793篇
  2017年   1825篇
  2016年   1931篇
  2015年   2060篇
  2014年   2295篇
  2013年   2712篇
  2012年   1910篇
  2011年   2076篇
  2010年   1809篇
  2009年   1928篇
  2008年   1646篇
  2007年   1477篇
  2006年   1378篇
  2005年   1240篇
  2004年   1072篇
  2003年   868篇
  2002年   746篇
  2001年   623篇
  2000年   396篇
  1999年   558篇
  1998年   655篇
  1997年   762篇
  1996年   693篇
  1995年   612篇
  1994年   457篇
  1993年   376篇
  1992年   313篇
  1991年   295篇
  1990年   290篇
  1989年   235篇
  1988年   179篇
  1987年   175篇
  1986年   165篇
  1985年   186篇
  1984年   129篇
  1983年   122篇
  1982年   97篇
  1981年   101篇
  1980年   69篇
  1979年   101篇
  1978年   76篇
  1977年   86篇
  1976年   82篇
  1972年   101篇
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
991.
992.
The purpose of this critical appraisal was to assess the available literature on the association of maternal obesity as a risk factor for childhood obesity and to explore the implications for incorporating this evidence into practice. The increasing prevalence of childhood obesity, with its documented adverse health effects, is a critical public health threat in the United States and worldwide. Research studies have documented increased rates of childhood obesity associated with maternal obesity. Healthcare providers are challenged to expand their competencies to recognize the association of maternal obesity and childhood obesity and to address both primary and secondary prevention of childhood obesity. Stopping the cycle of obesity before it becomes the leading cause of preventable disease and death in the United States is a priority for community health nurses.  相似文献   
993.
994.
995.
996.
Background The analysis of nursing errors in clinical management highlighted that clinical handover plays a pivotal role in patient safety. Changes to handover including conducting handover at the bedside and the use of written handover summary sheets were subsequently implemented. Aim The aim of the study was to explore nurses’ perspectives on the introduction of bedside handover and the use of written handover sheets. Method Using a qualitative approach, data were obtained from six focus groups containing 30 registered and enrolled (licensed practical) nurses. Thematic analysis revealed several major themes. Findings Themes identified included: bedside handover and the strengths and weaknesses; patient involvement in handover, and good communication is about good communicators. Finally, three sources of patient information and other issues were also identified as key aspects. Conclusions How bedside handover is delivered should be considered in relation to specific patient caseloads (patients with cognitive impairments), the shift (day, evening or night shift) and the model of service delivery (team versus patient allocation). Implications for nursing management Flexible handover methods are implicit within clinical setting issues especially in consideration to nursing teamwork. Good communication processes continue to be fundamental for successful handover processes.  相似文献   
997.
998.
Using an iterative structure–activity relationship driven approach, we identified a CNS-penetrant 5-(trifluoromethyl)-1,2,4-oxadiazole (TFMO, 12) with a pharmacokinetic profile suitable for probing class IIa histone deacetylase (HDAC) inhibition in vivo. Given the lack of understanding of endogenous class IIa HDAC substrates, we developed a surrogate readout to measure compound effects in vivo, by exploiting the >100-fold selectivity compound 12 exhibits over class I/IIb HDACs. We achieved adequate brain exposure with compound 12 in mice to estimate a class I/IIb deacetylation EC50, using class I substrate H4K12 acetylation and global acetylation levels as a pharmacodynamic readout. We observed excellent correlation between the compound 12 in vivo pharmacodynamic response and in vitro class I/IIb cellular activity. Applying the same relationship to class IIa HDAC inhibition, we estimated the compound 12 dose required to inhibit class IIa HDAC activity, for use in preclinical models of Huntington’s disease.  相似文献   
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号